To view or add a comment, sign in 1,890 followers
For glycemic control, the mean reduction in HbA1c across most T2DM subgroups approaches or reaches the commonly referenced threshold for clinical relevance of 0.5% 47 , and in key target populations (e.g., T2DM with obesity) can reach 0.81.0%, indicating clinically perceptible improvements
Sinke AP, Jayakumar AR, Panickar KS, Moriyama M, Reddy PV, Norenberg MD (2008) NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture
The GLP1 Pricing Data study, which analyzes comprehensive pricing data across the industry, focuses on the cost structures of GLP-1 medications, including compounded Semaglutide and Tirzepatide, as well as branded options